Medicines Patent Pool

🔬 🌍 “When we say this is a good project and we are putting money on it, the governments come behind, and say if they are doing it, we will follow suit” Pr Martin Friede, World Health Organization Coordinator of the #mRNA Technology Transfer Programme, demonstrating the effect of catalytic investment happening for most of the Programme Partners around the globe. 🤝 More on the high level event currently happening in Cape Town, 🇿🇦 👉 https://lnkd.in/eM-2Rv3K #TechnologyTransfer #mRNAprogramme

🌍 At the Subregional workshop on Trade and Public Health in #Bangkok 🇹🇭 co-hosted by the World Health Organization, the World Trade Organization, and the World Intellectual Property Organization – WIPO, 🎙️ MPP’s Mila Maistat showcased the power of MPP's public health-oriented voluntary licensing 👇🏽 ✅ Boosting awareness on other diseases beyond infectious diseases, investing in Universal Health Coverage, strengthening health systems, and creating sustainable access programs through MPP licensing are key to achieving UHC goals. #PublicHealth #GlobalHealth #Access2Meds

 On #WorldChildrensDay, MPP reaffirms its dedication to accelerating access to innovative paediatric medicines in low- and middle-income countries. ✨ At MPP, we believe in the transformative power of voluntary licensing and technology transfer to make life-saving therapies for children both accessible and affordable. 🔎 Read Charles Gore's message, prepared for #WorldPneumoniaDay, on the urgent need to accelerate access to respiratory syncytial virus (RSV) prevention therapies. RSV is a leading cause of severe respiratory infections in young children: 🔗https://bit.ly/40FGL4G #BetterMeds4Kids #GlobalHealth #PublicHealth #Access2Meds Unitaid, World Health Organization, World Pneumonia Day - Stop Pneumonia, Wellcome Trust, IAVI, ReSViNET | Respiratory Syncytial Virus (RSV) Foundation

On #WorldChildrensDay, we are excited to announce the release of the Paediatric Drug Optimization (PADO) report on #cancer medicines. 📑This report outlines the discussions & outcomes of the PADO process (led by GAP-f and the World Health Organization), a strategic approach to identify and prioritise the development of essential paediatric formulations. 🚸Each year, an estimated 400,000 children & adolescents develop cancer. 🧑🏾🤝🧑🏽The PADO–cancer exercise identified priority 🎯formulations for research & development, aligning efforts among funders, researchers, & manufacturers to address the needs of children with cancer in low- and middle-income countries🌍. 📄 Access the report > https://bit.ly/3V0mhA7 #ChildhoodCancer #BetterMeds4Kids St. Jude Children's Research Hospital, SIOP Europe, the European Society for Paediatric Oncology (SIOPE), Unitaid ©Scott A. Woodward, Persistent Productions, The Global Initiative for Childhood Cancer

🌟 New Video Alert ahead of #WorldChildrensDay ! 🌟    Discover the story of the Nyumbani Children's Home, a sanctuary for babies and children with #HIV in #Kenya🇰🇪. Nyumbani, meaning "home" in #Kiswahili, has transformed from a hospice into a loving home for approximately 100 orphans and vulnerable children.    📽️In this video, we explore the incredible advancements in paediatric HIV medicines, making it easier to provide care for these young ones. Learn about the upcoming rollout of paediatric #ALD, a fixed-dose combination for children living with HIV, and see firsthand the impact of access to adapted paediatric formulations in LMICs.    Watch the video now and be inspired by the resilience and hope of these amazing children. 💖 https://lnkd.in/g8ytu7B2 Children of God Relief Institute (COGRI), Nyumbani, Unitaid, Elizabeth Glaser Pediatric AIDS Foundation, Clinton Health Access Initiative, Inc. #NyumbaniChildrensHome #HIVAwareness #PaediatricHIV #GlobalHealth #BetterMeds4Kids 

📢 The Access to Medicine Index 2024 has just been released🎉 🧪Pharmaceutical innovations can save lives, but access is not guaranteed for all, especially in low- and middle-income countries🌍. 📄#ATMI24 evaluates 20 leading pharmaceutical companies on their efforts to expand access to their products in LMICs. It shows uneven progress, with many patients in LMICs still lacking access to essential medicines. 🎯The report identified key initiatives undertaken by pharmaceutical companies to support access to medicines in LMICs, but also identified notable gaps, particularly in addressing non-communicable diseases. 🫱🏽🫲🏾Some of these gaps could be addressed through partnerships with organisations like MPP. 🚀MPP plays a crucial role by facilitating voluntary licensing and technology transfer to make life-saving therapies more accessible and affordable. 📄 Access the full report: https://bit.ly/3YO9sKk #Access2Meds #GlobalHealth Access to Medicine Foundation

📢 Request for Proposal: 2024 Annual Report Design MPP is seeking proposals for the design of our 2024 Annual Report (print version). We’re looking for a creative partner with strong expertise in strategic and impactful design to help us tell the story of our work in #globalhealth and equitable access to medicines. 📅 Proposal Deadline: 02 December 2024 🔗 Learn more about the RFP: https://lnkd.in/d589QxPg #GlobalHealth #DesignRFP #AnnualReportDesign #MedicinesAccess #HealthEquity

📢 We're Hiring ❗ MPP is looking for an experienced Business Development & Partnerships Director to join our team in #Geneva 🇨🇭 . 🚀 This pivotal role is responsible for developing new business opportunities with pharmaceutical companies and research institutions, and managing relationships with our licensors and sublicensees. 🤝🏽 As a key member of the MPP Executive Leadership Team, you'll provide strategic business input and guidance, ensuring effective collaboration between MPP, originators, and sublicensees. You'll work closely with all MPP workstreams to negotiate and agree on appropriate licensing arrangements to achieve our public health objectives. 👥 The Business Development and Partnerships Director will report directly to the Executive Director and lead the business development workstream. If you're passionate about making a difference in global health and have the expertise to drive impactful partnerships, we want to hear from you! 🗓️ Application deadline: 8 December 2024. 🔗 Apply now and be part of our mission to improve access to essential medicines worldwide: https://lnkd.in/d8uRcx6H #JobOpening #BusinessDevelopment #Partnerships #GlobalHealth #JoinOurTeam

📢 Join us for the #MedsPaL Webinar! 📢 🙌🏽 We are thrilled to invite you to an insightful 1️⃣ hour Zoom webinar 💻 where we will unveil the enhanced MedsPaL interface. This webinar will provide a detailed overview of the new features, functionalities, and design improvements that make #MedsPaL an even more powerful tool 🚀. 🤓 MedsPaL is a free resource that provides crucial information on the intellectual property status of patented essential medicines, COVID-19 vaccines, and long-acting platform technologies, with a particular focus on low- and middle-income countries (LMICs). 🗓️ Date: Wednesday 27 November 🕘 Timeslots: 9:00-10:00 CET or 16:00-17:00 CET 🔗 Register here: https://lnkd.in/dbDefTgb We look forward to seeing you there! 🔎 medspal.org #MedsPaL #Webinar #IntellectualProperty #EssentialMedicines #COVID19 #GlobalHealth #PublicHealth World Intellectual Property Organization – WIPO

#DidYouKnow that 5️⃣ 3️⃣ 7️⃣ million adults worldwide live with #diabetes. And this number is expected to rise ⤴️. Shockingly, nearly half of these individuals are unaware of their condition, with 9️⃣ 0️⃣ % of undiagnosed cases found in low- and middle-income countries 🌍 . Less than 1️⃣ in 🔟 people with diabetes in these countries receive coverage of guideline-based appropriate diabetes treatment. ✊🏽 At MPP, we are committed to addressing these challenges by building partnerships with organisations to improve access to diabetes care in LMICs. 🤝🏽 Together, we can make a difference and ensure better health outcomes for all. 💻 Take a look at the medicines we’ve prioritised for voluntary licensing > https://bit.ly/3TPsnCP #WorldDiabetesDay #DiabetesAwareness #HealthForAll #GlobalHealth #PublicHealth International Diabetes Federation, Unitaid